← SynDRA
PIPERACETAZINE
SynDRA canonical compound SYN0011767 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Mechanism of action | dopamine receptor antagonist |
|---|
| Indication | schizophrenia |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- DRD2 ANTAGONIST
- Dopamine D2 receptor antagonist
- dopamine receptor antagonist
- DRD2 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CHRM3
- CHRM1
- HRH1
- HDAC6
- HTR2B
- KCNH2
- DRD3
- DRD1
- OPRK1
- HTR1A
- HTR2A
- ADRA1A
- SLC6A2
- SLC6A3
- ADRA2B
- ADRA2C
- SLC6A4
- SAMHD1
- MC3R
- TDP1
- TBXA2R
- HTR2C
- HTR3A
- IDH1
- MAOA
- NPY1R
- MLNR
- PTGS2
- NR1I2
- NR3C1
- OPRD1
- OPRM1
- SLC29A1
- PDE3A
- PDE4D
- PGR
- POLI
- ADORA1
- GMNN
- HRH3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- 5HT2A
- ACES
- ACM1
- ALR
- CP1A2
- CP2D6
- CP3A7
- ESR2
- GLI3
- KSYK
- MAPT
- MCL1
- SC5A7
- SYK
- TSHR
Cross-references
Synonyms
- QUIDE
- psymod
- quide
- Piperacetazina
- NSC-760067
- PC-1421
- Quide
- Psymod
- Piperacetazinum
- SC 9794
- NSC 760067
- KL6248WNW4
- NCGC00016642-01
- CAS-3819-00-9
- Piperacetazina [INN-Spanish]
- Piperazetazina
- Piperazetazina [DCIT]
- Piperacetazinum [INN-Latin]
- EINECS 223-312-0
- UNII-KL6248WNW4
- Piperacetazine [USAN:USP:INN]
- Quide (TN)
- Prestwick0_001048
- Prestwick1_001048
- Prestwick2_001048
- Prestwick3_001048
- 2-Acetyl-10-(3-(4-(beta-hydroxyethyl)piperidino)propyl)phenothiazine
- PIPERACETAZINE [MI]
- CHEMBL1584
- Piperacetazine (USAN/INN)
- PIPERACETAZINE [INN]
- BSPBio_000976
- PIPERACETAZINE [USAN]
- MLS002154124
- PIPERACETAZINE [VANDF]
- SCHEMBL148569
- SPBio_002908
Look up PIPERACETAZINE in the interactive SynDRA portal →